These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23749638)

  • 1. Percutaneous approaches for efficient cardiac gene delivery.
    Ishikawa K; Aguero J; Naim C; Fish K; Hajjar RJ
    J Cardiovasc Transl Res; 2013 Aug; 6(4):649-59. PubMed ID: 23749638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene delivery methods in cardiac gene therapy.
    Ishikawa K; Tilemann L; Fish K; Hajjar RJ
    J Gene Med; 2011 Oct; 13(10):566-72. PubMed ID: 21954037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy.
    Bishawi M; Roan JN; Milano CA; Daneshmand MA; Schroder JN; Chiang Y; Lee FH; Brown ZD; Nevo A; Watson MJ; Rowell T; Paul S; Lezberg P; Walczak R; Bowles DE
    Sci Rep; 2019 May; 9(1):8029. PubMed ID: 31142753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Adeno-Associated Virus Vector for Cardiac Gene Delivery in Large-Animal Surgical Models of Heart Failure.
    Katz MG; Fargnoli AS; Weber T; Hajjar RJ; Bridges CR
    Hum Gene Ther Clin Dev; 2017 Sep; 28(3):157-164. PubMed ID: 28726495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of gene therapy as a treatment for heart failure.
    Hajjar RJ
    J Clin Invest; 2013 Jan; 123(1):53-61. PubMed ID: 23281410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.
    Poller W; Hajjar R; Schultheiss HP; Fechner H
    Cardiovasc Res; 2010 Jun; 86(3):353-64. PubMed ID: 20176815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac gene therapy: from concept to reality.
    Kratlian RG; Hajjar RJ
    Curr Heart Fail Rep; 2012 Mar; 9(1):33-9. PubMed ID: 22143928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals.
    Kaye DM; Preovolos A; Marshall T; Byrne M; Hoshijima M; Hajjar R; Mariani JA; Pepe S; Chien KR; Power JM
    J Am Coll Cardiol; 2007 Jul; 50(3):253-60. PubMed ID: 17631218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
    Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
    J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A translatable, closed recirculation system for AAV6 vector-mediated myocardial gene delivery in the large animal.
    Swain JD; Katz MG; White JD; Thesier DM; Henderson A; Stedman HH; Bridges CR
    Methods Mol Biol; 2011; 709():331-54. PubMed ID: 21194039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in gene therapy for heart failure.
    Yerevanian A; Yerevanian A; Hajjar RJ
    J Cardiovasc Pharmacol; 2014 Feb; 63(2):95-106. PubMed ID: 23921315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Needleless Liquid Jet Injection Delivery Approach for Cardiac Gene Therapy.
    Fargnoli AS; Katz MG; Bridges CR
    Methods Mol Biol; 2017; 1521():219-226. PubMed ID: 27910052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy targets in heart failure: the path to translation.
    Raake PW; Tscheschner H; Reinkober J; Ritterhoff J; Katus HA; Koch WJ; Most P
    Clin Pharmacol Ther; 2011 Oct; 90(4):542-53. PubMed ID: 21866097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic editing of dysfunctional myocardium.
    Hajjar RJ; Huq F; Matsui T; Rosenzweig A
    Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current strategies for myocardial gene delivery.
    Katz MG; Swain JD; Tomasulo CE; Sumaroka M; Fargnoli A; Bridges CR
    J Mol Cell Cardiol; 2011 May; 50(5):766-76. PubMed ID: 20837022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in gene therapy for heart failure.
    Fish KM; Ishikawa K
    Discov Med; 2015 Apr; 19(105):285-91. PubMed ID: 25977191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure.
    Bass-Stringer S; Bernardo BC; May CN; Thomas CJ; Weeks KL; McMullen JR
    Heart Lung Circ; 2018 Nov; 27(11):1285-1300. PubMed ID: 29703647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical methods for cardiac gene transfer.
    Katz MG; Fargnoli AS; Williams RD; Bridges CR
    Future Cardiol; 2014 May; 10(3):323-6. PubMed ID: 24976468
    [No Abstract]   [Full Text] [Related]  

  • 20. Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure.
    del Monte F; Hajjar RJ; Harding SE
    Circ Res; 2001 Jun; 88(11):E66-7. PubMed ID: 11397790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.